Characteristics and outcomes of COVID ‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19198 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Yunfei Chen und 24 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, COVID-19, Thrombocytopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID‐19) pandemic has a significant impact on the immune system. This is the first and largest study on pre‐existing immune thrombocytopenia (ITP) patients infected with COVID‐19 in China. We prospectively collected ITP patients infected with COVID‐19 enrolled in the National Longitudinal Cohort of Hematological Diseases (NICHE, NCT04645199) and followed up for at least 1 month after infection. One thousand and one hundred forty‐eight pre‐existing ITP patients were included. Two hundred and twelve (18.5%) patients showed a decrease in the platelet (PLT) count after infection. Forty‐seven (4.1%) patients were diagnosed with pneumonia. Risk factors for a decrease in the PLT count included baseline PLT count
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, China.
- Department of Pediatric Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
ORCID-Profile: Yunfei Chen, Jiaying Liu, Wenjing Gu, Jia Chen, Yuan Xu, Dandan Yu, Lei Zhang
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Haihe Laboratory of Cell Ecosystem Innovation Fund
Zitieren
APA
Chen, Y., Liu, J., Shao, S., Song, Z., Ma, Y., Tuo, Y., Fang, L., Xu, Y., Xu, B., Gu, W., Cao, X., Chen, J., Yang, Y., Wang, P., Zhang, J., Xu, Y., Yu, D., Hou, P., Meng, K., …, & Zhang, L. (2024). Characteristics and outcomes of COVID ‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study. British Journal of Haematology. https://doi.org/10.1111/bjh.19198
Vancouver
Chen Y, Liu J, Shao S, Song Z, Ma Y, Tuo Y, et al. Characteristics and outcomes of COVID ‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study. British Journal of Haematology. 2024. doi:10.1111/bjh.19198
BibTeX
@article{Chen2024,
author = {Chen, Yunfei and Liu, Jiaying and Shao, Shuai and Song, Zhen and Ma, Yueshen and Tuo, Yuanyuan and Fang, Lijun and Xu, Yanmei and Xu, Bingqi and Gu, Wenjing and Cao, Xuan and Chen, Jia and Yang, Yu and Wang, Panjing and Zhang, Jing and Xu, Yuan and Yu, Dandan and Hou, Pengxiao and Meng, Ke and Li, Zhirong and Liu, Guanyu and Qu, Xinmiao and Ji, Lulu and Yang, Renchi and Zhang, Lei},
title = {Characteristics and outcomes of COVID ‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19198}
}
EUVIMED